Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Epidemiologic Study of Xolair (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma (EXCELS)

NCT00252135 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00252135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Epidemiologic Study of Xolair (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma (EXCELS)
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2004
Completion date
November 30, 2011
Enrollment
8,023 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma